As of 2026-04-21, the Fair Value of Helix BioMedix Inc (HXBM) is -33.82 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.00 USD, the upside of Helix BioMedix Inc is -3,481.73%.
With the market price of 1.00 USD and our fair value calculation, Helix BioMedix Inc (HXBM) is not a good investment. Investing in HXBM stocks now will result in a potential loss of 3,481.73%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2007-12-31 | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2011-12-31 | 5Y Avg | |
| Net income | -3.43 | -4.52 | -3.78 | -7.71 | -2.49 | -4.38 |
| YoY growth | 10.25% | -31.51% | 16.41% | -104.26% | 67.73% | -8.28% |
| Market Cap (mil) | 0.38 |
| P/E | |
| Forward P/E |
| EPS | -6.76 |
| Avg earnings growth rate | -8.28% |
| TTM earnings | -2.58 |